Derakhshandeh-Peykar Pupak, Akhavan-Niaki Haleh, Tamaddoni Ahmad, Ghawidel-Parsa Shohreh, Naieni Kourosh Holakouie, Rahmani Manijeh, Babrzadeh Farbod, Dilmaghani-Zadeh Mohammad, Farhud Dariush Daneshvar
Department of Medical Genetics, Medical Sciences, University of Tehran, Tehran, Iran.
Hemoglobin. 2007;31(3):351-6. doi: 10.1080/03630260701462030.
Beta-Thalassemia (thal) is one of the most common autosomal recessive disorders in Iran. There are more than two million carriers of beta-thal and over 15,000 people affected with beta-thal major who live in Iran. Prevalent mutations were identified by examining genomic DNAs isolated from 392 blood samples of beta-thal carriers from three northern provinces of Iran. Furthermore, 172 pregnant women were analyzed from the 196 couples who requested pregnant diagnosis for beta-thal. Allele identification was carried out using routine reverse dot-blot, amplification refractory mutation system (ARMS), and genomic sequencing. The most common mutation, IVS-II-1 (GA), is followed, in order of frequency, by codon 30 (GC), frameshift codons (FSC) 8,9 (+G), FSC 22/23/24 (-AAGTTGG), IVS-I-110 (GA), IVS-I-5 (GC), IVS-II-745 (CG), IVS-I-2 (TC), FSC 8 (-AA), IVS-I,3'-end (-25 bp), IVS-I-1 (GA), FSC 36/37 (-T), IVS-I-6 (TC), FSC 5 (-CT), -28 (AC), codon 37 (GA), IVS-II-2,3 (+11/-2), -30 (TA), and -88 (CA). We have also revealed the existence of five new mutations from northern Iran, one of which (codon 37) is the first reported for Iran. Furthermore, the rate of unknown mutations is significantly reduced in our study (about 6%). These results could help with establishing a center for prenatal diagnosis, prevention, and control of thalassemia in the northern provinces of Iran.
β地中海贫血是伊朗最常见的常染色体隐性疾病之一。伊朗有超过200万β地中海贫血基因携带者以及超过15000名重型β地中海贫血患者。通过检测从伊朗北部三个省份的392名β地中海贫血携带者的血样中分离出的基因组DNA,确定了常见突变。此外,对196对要求进行β地中海贫血孕期诊断的夫妇中的172名孕妇进行了分析。使用常规反向点杂交、扩增阻滞突变系统(ARMS)和基因组测序进行等位基因鉴定。最常见的突变是IVS-II-1(GA),按频率依次为密码子30(GC)、移码密码子(FSC)8,9(+G)、FSC 22/23/24(-AAGTTGG)、IVS-I-110(GA)、IVS-I-5(GC)、IVS-II-745(CG)、IVS-I-2(TC)、FSC 8(-AA)、IVS-I,3'-末端(-25 bp)、IVS-I-1(GA)、FSC 36/37(-T)、IVS-I-6(TC)、FSC 5(-CT)、-28(AC)、密码子37(GA)、IVS-II-2,3(+11/-2)、-30(TA)和-88(CA)。我们还发现了来自伊朗北部的五个新突变,其中一个(密码子37)是伊朗首次报道的。此外,在我们的研究中未知突变率显著降低(约6%)。这些结果有助于在伊朗北部省份建立一个地中海贫血产前诊断、预防和控制中心。